Immunopathological prognostic and predictive factors in prostate cancer.
Prostate cancer is the leading male malignancy in the Western world. Patients with prostate cancer have an unpredictable clinical course, as three biologically different types of tumor exist. This review summarises some of the recent progress made in understanding the biology of prostate cancer with special reference to the prognostic and predictive role of immunohistochemical markers. The prognostic value of established prognostic variables is also discussed.
Sivridis
E
E
Department of Pathology, Democritus University of Thrace, Alexandroupolis, Greece. esivrid@med.duth.gr
Touloupidis
S
S
Giatromanolaki
A
A
D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000276:immunology* / Q000473:pathology*